Roswell Park Cancer Institute Rosewell — Buffalo, New York

Roswell Park Cancer Institute Rosewell is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Institute Rosewell has participated in 2 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer, Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Institute Rosewell?

Roswell Park Cancer Institute Rosewell has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Institute Rosewell conducted?

Roswell Park Cancer Institute Rosewell has 2 clinical trials on record. Their work covers Non-small Cell Lung Cancer, Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Is Roswell Park Cancer Institute Rosewell accredited by Crixeo Health?

Roswell Park Cancer Institute Rosewell has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Institute Rosewell?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.